Factors associated with celecoxib, rofecoxib use in the US

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.479, 2005-01, pp. : 9-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Renal Failure Associated with the Use of Celecoxib and Rofecoxib

By Ahmad S.R. Kortepeter C. Brinker A. Chen M. Beitz J.

Drug Safety, Vol. 25, Iss. 7, 2002-01 ,pp. : 537-544

Adis International

Access to resources Recommend Favorite

Celecoxib associated with similar cardiovascular risk to rofecoxib

Reactions Weekly, Vol. 1, Iss. 1048, 2005-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Cardiovascular Events Associated with Long-Term Use of Celecoxib, Rofecoxib and Meloxicam in Taiwan: An Observational Study

By Huang Weng-Foung

Drug Safety, Vol. 29, Iss. 3, 2006-01 ,pp. : 261-272

Adis International

Access to resources Recommend Favorite

Celecoxib, rofecoxib use inconsistent with good clinical practice

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 411, 2003-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Celecoxib, rofecoxib use often inappropriate in Australia

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 419, 2003-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite